Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study

ConclusionThis study highlights the treatment toxicity and associated economic burden among patients with CCL in the USA. As novel therapies are increasingly used, further research examining outcomes will inform the risks, benefits, and value of novel agents to prescribers and patients.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research